Andrew J. Murphy mainly investigates Immunology, Internal medicine, Endocrinology, Inflammation and Cell biology. His Immunology research incorporates themes from Progenitor cell and Haematopoiesis. He combines subjects such as Mutation and Human genetics with his study of Internal medicine.
Within one scientific family, Andrew J. Murphy focuses on topics pertaining to Monocyte under Endocrinology, and may sometimes address concerns connected to Integrin, Platelet activation, Tangier disease, Scavenger receptor and Cell adhesion. The various areas that Andrew J. Murphy examines in his Inflammation study include Receptor, Innate immune system, Macrophage and Pathogenesis. His studies in Cell biology integrate themes in fields like Regulation of gene expression, Biochemistry and Gene.
Andrew J. Murphy focuses on Immunology, Internal medicine, Antibody, Endocrinology and Cell biology. In his study, which falls under the umbrella issue of Immunology, Cancer research is strongly linked to Haematopoiesis. Andrew J. Murphy usually deals with Internal medicine and limits it to topics linked to Diabetes mellitus and Disease.
His Antibody research is multidisciplinary, relying on both Transgene, Receptor, Biochemistry, Antigen and Molecular biology. His Endocrinology research is multidisciplinary, incorporating perspectives in Apolipoprotein E and ABCA1. His Cell biology research is multidisciplinary, incorporating elements of Cell and Angiogenesis.
Andrew J. Murphy spends much of his time researching Antibody, Immunology, Inflammation, Cancer research and Cell biology. His Antibody research includes elements of Receptor, Severe acute respiratory syndrome coronavirus 2, Fusion protein and Virology. His research integrates issues of Diabetic foot and Myocardial infarction in his study of Immunology.
The study incorporates disciplines such as Diabetes mellitus, Myelopoiesis, Rheumatoid arthritis and Interleukin 4 in addition to Inflammation. His Cancer research study incorporates themes from Haematopoiesis, Stem cell, Gene, T-cell receptor and Immunotherapy. His Cell biology research incorporates elements of Genetically modified mouse and Immune system.
Andrew J. Murphy focuses on Inflammation, Immunology, Cancer research, Diabetes mellitus and Antibody. His biological study spans a wide range of topics, including Generalized pustular psoriasis, Cytokine, Myelopoiesis and Rheumatoid arthritis. He interconnects Myocardial infarction and Granulopoiesis in the investigation of issues within Immunology.
His Diabetes mellitus study incorporates themes from Internal medicine and Disease. His study in Antibody is interdisciplinary in nature, drawing from both Severe acute respiratory syndrome coronavirus 2, Coronavirus and Virology. His study focuses on the intersection of Inflammasome and fields such as Cellular differentiation with connections in the field of Cell biology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Regulation of the germinal center response by microRNA-155.
To-Ha Thai;Dinis Pedro Calado;Stefano Casola;K. Mark Ansel.
Science (2007)
Mammalian Sir2 homolog SIRT3 regulates global mitochondrial lysine acetylation.
David B. Lombard;Frederick W. Alt;Hwei Ling Cheng;Jakob Bunkenborg.
Molecular and Cellular Biology (2007)
Methods of Modifying Eukaryotic Cells
Andrew J. Murphy;George D. Yancopoulos.
(2002)
CD133 expression is not restricted to stem cells, and both CD133 + and CD133 – metastatic colon cancer cells initiate tumors
Sergey V. Shmelkov;Jason M. Butler;Andrea T. Hooper;Adilia Hormigo.
Journal of Clinical Investigation (2008)
Innate and adaptive interleukin-22 protects mice from inflammatory bowel disease
Lauren A. Zenewicz;George D. Yancopoulos;David M. Valenzuela;Andrew J. Murphy.
Immunity (2008)
Interleukin-22 but not interleukin-17 provides protection to hepatocytes during acute liver inflammation.
Lauren A. Zenewicz;George D. Yancopoulos;David M. Valenzuela;Andrew J. Murphy.
Immunity (2007)
Haploinsufficiency of delta-like 4 ligand results in embryonic lethality due to major defects in arterial and vascular development
Nicholas W. Gale;Melissa G. Dominguez;Irene Noguera;Li Pan.
Proceedings of the National Academy of Sciences of the United States of America (2004)
High-throughput engineering of the mouse genome coupled with high-resolution expression analysis.
David M Valenzuela;Andrew J Murphy;David Frendewey;Nicholas W Gale.
Nature Biotechnology (2003)
IL-22BP is regulated by the inflammasome and modulates tumorigenesis in the intestine
Samuel Huber;Nicola Gagliani;Lauren A. Zenewicz;Francis J. Huber.
Nature (2012)
Generation of functional multipotent adult stem cells from GPR125 + germline progenitors
Marco Seandel;Marco Seandel;Daylon James;Sergey V. Shmelkov;Ilaria Falciatori.
Nature (2007)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Regeneron (United States)
Regeneron (United States)
Regeneron (United States)
Columbia University
Regeneron (United States)
Yale University
Monash University
Regeneron (United States)
Institut Pasteur
New York University
Sorbonne University
National University of Singapore
Princeton University
Instituto Superior Técnico
University of Sassari
University of California, Santa Barbara
Istituto Superiore di Sanità
Columbia University
University of Hull
Yonsei University
University of Cambridge
New York University
Tufts University
New York University
The Ohio State University
George Mason University